NDC 71288-201

Regadenoson

Regadenoson

Regadenoson is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Regadenoson.

Product ID71288-201_347eb6ed-dadc-4127-be90-24f65150fbff
NDC71288-201
Product TypeHuman Prescription Drug
Proprietary NameRegadenoson
Generic NameRegadenoson
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-04-11
Marketing CategoryANDA /
Application NumberANDA212806
Labeler NameMeitheal Pharmaceuticals Inc.
Substance NameREGADENOSON
Active Ingredient Strength0 mg/mL
Pharm ClassesAdenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71288-201-85

1 SYRINGE, PLASTIC in 1 CARTON (71288-201-85) > 5 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2022-04-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Regadenoson" or generic name "Regadenoson"

NDCBrand NameGeneric Name
55150-443regadenosonregadenoson
68083-175RegadenosonRegadenoson
71288-201RegadenosonRegadenoson
0469-6501LEXISCANregadenoson

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.